Lyell Immunopharma, Inc.
LYEL
Revenue
34.00k
▲21.00k▲161.54%
3 Months ChangeAssets
619.22M
▼-34.93M▼-5.34%
3 Months ChangeLiabilities
88.52M
▲877.00k▲1.00%
3 Months ChangeFree Cash Flow
-42.05M
▲5.70M▲11.94%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 8-K
ID: 0001193125-24-248760
2024-10-24
Form 8-K
ID: 0001193125-24-242808
2024-08-07
Form 10-Q
ID: 0001628280-24-035617
2024-08-07
Form 8-K
ID: 0001628280-24-035603
2024-06-26
Form 8-K
ID: 0001193125-24-168597
2024-06-14
Form 8-K
ID: 0001193125-24-161601
2024-05-06
Form 10-Q
ID: 0001628280-24-020467
2024-05-06
Form 8-K
ID: 0001628280-24-020466
2024-02-28
Form 8-K
ID: 0001628280-24-007579
2023-11-20
Form 8-K
ID: 0001193125-23-280680